Short duration response-guided treatment is effective for most individuals with recent hepatitis C infection: the ATAHC II and DARE-C I studies

M Martinello, M Hellard, D Shaw, K Petoumenos, T Applegate, J Grebely, B Yeung, L Maire, D Iser, A Lloyd, A Thompson, J Sasadeusz, P Haber, GJ Dore, GV Matthews